By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Sophiris Bio Inc.  

1258 Prospect Street

La Jolla  California  92037  U.S.A.
Phone: 858-777-1760 Fax: n/a


SEARCH JOBS

Sophiris Bio is a biopharmaceutical company developing PRX302, a clinical-stage, targeted therapy for the treatment of urological diseases.

YEAR FOUNDED:

May 2003

LEADERSHIP:

CEO: Randall Woods

CFO: Peter Slover

CLINICAL TRIAL:

Please click here for clinical trial information.


Key Statistics


Email: info@sophirisbio.com
Ownership: Public

Web Site: Sophiris Bio
Employees:
Symbol: SPHS
 



Industry
Pharmaceutical






Company News
Sophiris Bio (SPHS) Reports Third Quarter 2016 Financial Results And Key Business Highlights 11/10/2016 4:42:43 PM
Sophiris Bio (SPHS) To Present At The 2016 BIO Investor Forum 10/11/2016 8:50:25 AM
5 Biotechs Under $10 With Massive Potential 9/6/2016 6:19:02 AM
Sophiris Bio (SPHS) Closes Underwritten Public Offering 8/29/2016 8:52:07 AM
Sophiris Bio (SPHS) Prices Public Offering Of Common Shares And Warrants 8/23/2016 7:31:27 AM
Sophiris Bio (SPHS) Announces Proposed Public Offering Of Common Shares And Warrants 8/23/2016 6:57:29 AM
SoCal's Sophiris Bio (SPHS) Evaluating Options, Will Not Pursue New Clinical Trials Unless New Financing is Obtained 8/23/2016 6:28:48 AM
Sophiris Bio (SPHS) Reports Second Quarter 2016 Financial Results And Key Business Highlights 8/10/2016 9:04:49 AM
Sophiris Bio (SPHS) Reports Successful Results From Completed Phase 2a Study Of Topsalysin In Localized Prostate Cancer 6/10/2016 8:18:40 AM
Sophiris Bio (SPHS) Slashes Workforce in Half as Firm Explores Strategic Options 5/25/2016 7:03:24 AM
1234567
//-->